PL EN


Preferences help
enabled [disable] Abstract
Number of results
2017 | 28 | 108 | 189-195
Article title

Lentinula edodes (Shiitake) – biological activity

Content
Title variants
Languages of publication
EN EO
Abstracts
EN
Lentinula edodes (Berk.) Pegler (shiitake) is a species with medicinal properties that is used primarily in traditional medicine, but also in conventional oncology treatment. The first records of Lentinula edodes cultivation reach back to China under the Song dynast (960-1127). The Japanese adopted the Chinese technique of shiitake cultivation, thus becoming its main producer. Currently, shiitake is used in the treatment of lifestyle diseases. Polysaccharides contained in this species strengthen the immune system, eliminate side effects of chemo and radiotherapy and have strong antitumor, antiviral and antibacterial properties. The year 1972 saw a discovery of substances with anti-atherosclerotic effects, with the most important being eritadenine (2 (R), 3 (R)-dihydroxy-4 – (9-adanyl) butyric acid) and statin – lovastatin. L. edodes is of interest to researchers due to its content of therapeutic compounds. These substances have antitumor, antifungal, antibacterial, anti-inflammatory, hypocholesterolemic, antihypertensive, hypoglycaemic and antioxidant effects.
Discipline
Publisher

Year
Volume
28
Issue
108
Pages
189-195
Physical description
Contributors
  • Department of Pharmaceutical Botany, Faculty of Pharmacy, Jagiellonian University Medical College, Kraków, Poland
author
References
  • 1. Akramiene D.; Kondrotas A.; Didziapetriene J.; Kevelaitis E. Medicina (Kaunas). 2007, 43, 597-606.
  • 2. Wasser, S. P. Encycl. Diet. Suppl. 2005, 653–664.
  • 3. Wasser S.P.; Weis A.L. Int. J. Med. Mushr. 1999, 1, 31-62.
  • 4. Casaril, K. B. P. B.; Kasuya, M. C. M.; Vanetti, M. C. D. Brazilian Arch. Biol. Technol. 2011, 54 (5), 991–1002.
  • 5. Chihara, G.; Maeda, Y.; Hamuro, J.; Sasaki, T.; Fukuoka, F. Nature 1969, 222 (5194), 687–688.
  • 6. Muta T. Curr. Pharm. Des. 2006, 12, 4155-4161.
  • 7. Bak, W. C.; Park, J. H.; Park, Y.; Ka, K. H. Mycobiology 2014, 42 (3), 301–304.
  • 8. Mizuno, T. Food Rev. Int. 1995, 11 (1), 109–128.
  • 9. Kamiya, T.; Saito, Y.; Hashimoto, M.; Seki, H. Tetrahedron Lett. 1969, 10 (53), 4729–4732.
  • 10. Morales, D.; Gil-Ramirez, A.; Smiderle, F. R.; Piris, A. J.; Ruiz-Rodriguez, A.; Soler-Rivas, C. Innov. Food Sci. Emerg. Technol. 2017, 41, 330-336.
  • 11. Drori, A.; Shabat, Y.; Ben Ya’acov, A.; Danay, O.; Levanon, D.; Zolotarov, L.; Ilan, Y. J. Med. Food 2016, 19 (4), 383–389.
  • 12. Mleczek, M.; Siwulski, M.; Rzymski, P.; Niedzielski, P.; Gąsecka, M.; Jasińska, A.; Budzyńska, S.; Budka, A. J. Environ. Sci. Heal. Part B 2017, 52 (3), 196–205.
  • 13. Kurashige, S.; Akuzawa, Y.; Endo, F. Immunopharmacol. Immunotoxicol. 1997, 19 (2), 175–183.
  • 14. Ogawa, T.; Ohwada, S.; Sato, Y.; Izumi, M.; Nakamura, S.; Takeyoshi, I.; Kawashima, Y.; Ohya, T.; Koyama, T.; Morishita, Y. Anticancer Res. 1998, 19 (1A), 375–379.
  • 15. Murata, T.; Hatayama, I.; Kakizaki, I.; Satoh, K.; Sato, K.; Tsuchida, S. Cancer Sci. 1996, 87 (11), 1171–1178.
  • 16. Kamiya, T.; Saito, Y.; Hashimoto, M.; Seki, H. J. Heterocycl. Chem. 1972, 9 (2), 359–362.
  • 17. Nakano, H.; Namatame, K.; Nemoto, H.; Motohashi, H.; Nishiyama, K.; Kumada, K. Hepatogastroenterology. 1999, 46 (28), 2662–2668.
  • 18. Yoshino, S.; Tabata, T.; Hazama, S.; Iizuka, N.; Yamamoto, K.; Hirayama, M.; Tangoku, A.; Oka, M. Anticancer Res. 1999, 20 (6C), 4707–4711.
  • 19. Takatsuki, F.; Namiki, R.; Kikuchi, T.; Suzuki, M.; Hamuro, J. Int. J. Immunopharmacol. 1995, 17 (6), 465471–469474.
  • 20. Fukushima, M.; Ohashi, T.; Fujiwara, Y.; Sonoyama, K.; Nakano, M. Exp. Biol. Med. 2001, 226 (8), 758–765.
  • 21. Hirasawa, M.; Shouji, N.; Neta, T.; Fukushima, K.; Takada, K. Int. J. Antimicrob. Agents 1999, 11 (2),151–157.
  • 22. Kawanobe, Y.; Sakamoto, M.; Nishioka, K. Nutr. Res. 1988, 8 (11), 1277–1286.
  • 23. Takeshita, K.; Hayashi, S.; Tani, M.; Kando, F.; Saito, N.; Endo, M. Surg. Oncol. 1996, 5 (1), 23–28.
  • 24. Masihi, K. N.; Madaj, K.; Hintelmann, H.; Gast, G.; Kaneko, Y. Int. J. Immunopharmacol. 1997, 19 (9–10), 463–468.
  • 25. Suzuki, M.; Iwashiro, M.; Takatsuki, F.; Kuribayashi, K.; Hamuro, J. Cancer Sci. 1994, 85 (4), 409–417.
  • 26. Liu, F.; Ooi, V. E. C.; Fung, M. C. Life Sci. 1999, 64 (12), 1005–1011.
  • 27. Jong, S. C.; Birmingham, J. M. Adv. Appl. Microbiol. 1993, 39, 153–184.
  • 28. Rincão, V. P.; Yamamoto, K. A.; Ricardo, N. M. P. S.; Soares, S. A.; Meirelles, L. D. P.; Nozawa, C.; Linhares, R. E. C. Virol. J. 2012, 9 (1), 37.
  • 29. Turlo, J.; Gutkowska, B.; Herold, F.; Dawidowski, M.; Słowiński, T.; Zobel, A. J. Toxicol. Environ. Heal. Part A 2010, 73 (17–18), 1211–1219.
  • 30. Hirasawa, M.; Shouji, N.; Neta, T.; Fukushima, K.; Takada, K. Int. J. Antimicrob. Agents 1999, 11 (2),151–157.
Document Type
article
Publication order reference
Identifiers
YADDA identifier
bwmeta1.element.psjd-c11f7058-e320-495a-985e-d14c8c7d85fa
JavaScript is turned off in your web browser. Turn it on to take full advantage of this site, then refresh the page.